Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

5.5 million and $11.0 million in the second quarter and first half of 2013, respectively.

Net loss in the second quarter of 2014 was $32.6 million or $0.26 loss per share as compared to $42.7 million or $0.37 loss per share in the second quarter of 2013. Net loss in the first half of 2014 was $78.8 million or $0.63 loss per share as compared to $97.8 million or $0.85 loss per share in the first half of 2013.

The company also announced upcoming presentations at the following medical meetings and scientific congresses during the third and fourth quarters of 2014:

Global Cancer Conference 2014, Hyderabad, India:

  • Oral Abstract Title: "NKTR-214: A long-acting, engineered immunotherapy shows excellent therapeutic efficacy in multiple syngeneic mouse tumor models both alone and in combination with checkpoint inhibition", Addepalli, M., et al. 
  • Date: September 15-17, 2014
  • IASP 15th World Congress on Pain, Buenos Aires, Argentina:

  • Abstract/Poster Title: "Multi-dimensional pathway analysis reveals unique pharmacological signatures of kappa opioid receptor agonists", Brew, C., et al. 
  • Date: October 10, 2014, 9:30 a.m. Argentina Time
  • Society for Neuroscience, Washington, DC:

  • Abstract/Poster Title: "SEO-16: An orally active opioid analgesic with rapid onset of activity and reduced CNS side effects", Harrison, S., et al. 
  • Poster Session 244: "Opioids and other analgesics"
  • Date: November 16, 2014, 1:00 p.m. — 5:00 p.m. Eastern Time
  • Conference Call to Discuss Second Quarter 2014 Financial ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time today, Thursday, July 31, 2014.

    This press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
    2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
    3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
    5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
    6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
    7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
    8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
    9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
    10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
    11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... 26, 2015  IRIDEX Corporation (NASDAQ: IRIX ) ... full year 2014 financial results after the market closes on ... release, the Company will host a conference call with the ... Thursday, March 5, 2015 to discuss the results ... parties may access the live conference call via telephone by ...
    (Date:2/26/2015)... Feb. 26, 2015  Mail-service and specialty pharmacies ... employers and government health plans $23.3 billion over ... the Pharmaceutical Care Management Association (PCMA). ... one of the easiest ways to reduce health ... Merritt . "Policymakers should resist efforts to restrict ...
    (Date:2/26/2015)... N.Y. , Feb. 26, 2015 Every ... more research to fight heart disease.  Nevertheless, year after ... on ElectroCardioGrams (EKG) as the first test to determine ... they have chest pain or not, even though that ... occurs despite the fact that doctors know, (while most ...
    Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2
    ... of Gynecologic Oncologists, Annual ... Meeting on Women,s Cancer -, FREMONT, Calif. ... a molecular diagnostics company,presented data from several studies demonstrating the benefits ... use,of Vermillion,s biomarkers could help better identify women with ovarian,cancer, as ...
    ... longest duration of consistently ... cancer vaccine, TAMPA, Fla., March 10 New ... candidate vaccine,CERVARIX(R) provides significant protection for women against the ... six and a half,years, the longest duration of protection ...
    Cached Medicine Technology:Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 2Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 3Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 4Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease 5GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 2GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 3GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 4GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 5GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 6
    (Date:2/28/2015)... February 28, 2015 National ... outsourced sales, marketing and supply chain management for ... Botanicals, is bringing its award winning solutions for ... Botanicals’ products are specifically created to combat thinning-damaged ... BIOTA is committed to marrying science with nature ...
    (Date:2/28/2015)... New York, NY (PRWEB) February 28, 2015 ... to discuss federal testosterone lawsuits that have been filed ... scheduled for the second week in March, the Firm ... the Court’s website, parties involved in the federal litigation ... to address matters related to prescription therapy treatments designed ...
    (Date:2/28/2015)... February 28, 2015 On Thursday, February 26th, ... It Easy For Scammers To Steal Your Data , which ... their hands on a DIY phishing kit, or any kind ... touched on another important point about how everyone’s cyber security ... often implemented, “like compromising legitimate content management systems or blogs ...
    (Date:2/28/2015)... Developers of FCPX plugins and ... plugin for Final Cut Pro X entitled FCPX Overlay Chromatic ... gives users total control over 6k lens dirt overlays inside ... Film Studios. “FCPX Overlay Chromatic was professionally designed to add ... , FCPX Overlay Chromatic Grunge 6K is a resourceful tool ...
    (Date:2/28/2015)... (PRWEB) February 28, 2015 Plugin creators ... TransFold Volume 2. A fully customizable transition ... “TransFold Volume 2 gives users total control over 30 ... Austin, CEO of Pixel Film Studios. “TransFold Volume 2 ... editor.” , TransFold Volume 2 from Pixel Film Studios ...
    Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
    ... at Thomas Jefferson University Hospital are combining efforts to determine ... some forms of migraine headaches. ,Investigators from the ... participants in a blinded study to determine if closing a ... can allow blood to flow between the right and left ...
    ... exposed to family turmoil, violence, noise, poor housing or ... on their organs and tissues than other young people. ... they do not experience these negative physiological changes, reports ... research group also found that the cardiovascular systems of ...
    ... with Medicare to make the most of Medicare’s preventive services, ... Human Services (HHS) and the Centers for Medicare and Medicaid ... Here. , It has been decided ... bus will visit each of the 48 states to promote ...
    ... the socio-educational environment in the US that is responsible for ... that it is wrong to blame any individual as is ... Korean, held responsible the worst college shoot-out in that country ... the family of Cho said, "We are humbled by ...
    ... replacement products claiming to be safe and natural alternatives to ... the warnings of breast cancer, ovarian cancer and the like. ... (FTC), had found around 34 websites guilty of violating ... of claims and as well as federal permission. According to ...
    ... early treatment with the antiviral drug Tamiflu have the best ... than good, the World Health Organization (WHO) said on Friday. ... preliminary conclusions of international experts who met last month in ... doctors in some countries to use steroids as well. ...
    Cached Medicine News:Health News:Jefferson Researchers Want to Learn If Heart Defect 'at Heart' of Some Migraines 2Health News:Family Turmoil and Violence Results in Stress-induced Physical Problems in Young, Cornell Psychologist Finds 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2Health News:Fault the School System in US for Massacres, Say Sociologists 2Health News:Fault the School System in US for Massacres, Say Sociologists 3Health News:Fault the School System in US for Massacres, Say Sociologists 4Health News:Hormones- The Same Regardless Of Packaging 2Health News:Tamiflu Key to Treat Bird Flu, Avoid Steroids: WHO 2
    Exo-Deluxe Overhead Traction for hospital or home care. Twice the clearance of other units between the patient and supporting wall. 2" nylon pulleys with polypropylene cord, head halter, spreader bar...
    ... Aspen® Cervical Collars improves patient ... overall costs. Adjusts to user's anatomy, ... transfers head weight to shoulders and ... patient. Front and back airflow openings. ...
    Wonderflex™ is a lined soft durometer silicone gel sheet. It is ideal for cushioning orthotic/prosthetic devices and offers protection from shock and sheer forces. Wonderflex can also be lamina...
    ... binder has a variety of applications. Its ... for post-surgical dressings. It is effective in ... loss of muscle tone. It can also ... painful expansion of the chest in the case ...
    Medicine Products: